BioWorld MedTech

Aug. 29, 2012

Aesthetics is going strong while orthopedics struggles

German valve registry reveals real-world TAVI experience

MUNICH, Germany — Minimally invasive aortic valve replacement accounted for 28% of procedures in Germany in 2011, the year following approval of the procedure for reimbursement. Read More

PROTECT trial vindicates DES for long-term benefits

GE Healthcare's Discovery well suited for Hybrid OR

Medtronic reports results from Symplicity HTN-2 trial

Deals roundup: MM to acquire Ascender for undisclosed amount

Court Report: Medtronic expands patent lawsuit against Nuvasive

Med-Tech Notes

Agreements/contracts: PerkinElmer works with Mass Gen on sequencing

HIT roundup: EHNAC set to discuss PHI protection in upcoming webinar

Financings roundup: Nextremity closes $6.6M; opens first preferred round

People in the News

Product Briefs

Medgenics board member Brukardt dies at age 66

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...

Virtual IPO word with stock graph and arrow

Parabilis takes top spot, pricing largest biopharma IPO at $670M

BioWorld

Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...